Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 7, 2019; 25(29): 3941-3955
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3941
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3941
Figure 4 Honokiol-derived tumour cell lysates pulsed dendritic cells significantly stimulated T lymphocyte proliferation.
KKU-213L5 cells were pretreated with honokiol or left untreated before they were lysed and loaded into dendritic cells (DCs). T lymphocytes were stimulated with different types of DCs (unpulsed, pulsed with tumour cell lysates and pulsed with honokiol-derived tumour cell lysates) at 1:10 ratios for 5 d. Lymphocyte number was reflected by direct counting (A) and relative lymphocyte proliferation (B). T lymphocytes cultured alone were set as control and all experiments were performed in triplicate. Results are shown as mean ± SD, A P value < 0.05 was considered significant; aP < 0.05, bP < 0.01 and cP < 0.001. DCs: Dendritic cells; HOK: Honokiol; TCL: Tumour cell lysate.
- Citation: Jiraviriyakul A, Songjang W, Kaewthet P, Tanawatkitichai P, Bayan P, Pongcharoen S. Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns. World J Gastroenterol 2019; 25(29): 3941-3955
- URL: https://www.wjgnet.com/1007-9327/full/v25/i29/3941.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i29.3941